2023
DOI: 10.1002/agm2.12238
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of risk scores as predictors of mortality and hospital length of stay for older COVID‐19 patients

Abstract: Three years after the first case of coronavirus disease 2019 , more than 500 million confirmed cases and more than 6 million deaths have been reported worldwide. 1 Immunodeficiency syndromes, comorbidities, frailty, and advanced age are risk factors for severe disease and mortality. 2 The case fatality rate has been reported as 8% in patients aged 70-79 years and 15% in those ≥80 years. 3 Initial clinical symptoms and key biochemical parameters have been associated with disease severity. Lymphopenia, elevated … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…Although prognostic markers unique to metabolic syndrome have not been defined, these individuals are likely to have higher perturbations of the above markers. Several prognostic calculators incorporating the clinical, radiological, haematological and biochemical factors have been designed and their use can facilitate triaging the at-risk patients for escalation of care [58] .…”
Section: Preventing and Managing Covid-19 In People With Metabolic Sy...mentioning
confidence: 99%
“…Although prognostic markers unique to metabolic syndrome have not been defined, these individuals are likely to have higher perturbations of the above markers. Several prognostic calculators incorporating the clinical, radiological, haematological and biochemical factors have been designed and their use can facilitate triaging the at-risk patients for escalation of care [58] .…”
Section: Preventing and Managing Covid-19 In People With Metabolic Sy...mentioning
confidence: 99%
“…In addition, traditional pain management methods often cannot fully meet the individual needs of patients, resulting in poor analgesia or excessive analgesia. 7 Elderly patients are a special population who have obvious differences from young people in terms of physiology, psychology, tumor condition, and their surgical tolerance and risk: they have multiple chronic diseases such as hypertension, coronary heart disease, heart failure, chronic obstructive pulmonary disease, etc; [8][9][10] they are more prone to cognitive impairment, depression, anxiety and other psychological problems; their tumor biology behavior is more malignant; all these lead to the need for more safe, effective, accurate, and less traumatic intervention methods for anesthesia and perioperative management process of elderly patients. 2,4,6,11 Ultrasound-guided thoracic paravertebral block (UG-TPVB) is a technique that injects local anesthetics to the paravertebral space where the spinal nerves exit from the intervertebral foramen under ultrasound guidance, thereby producing unilateral (ipsilateral), segmental, somatic, and sympathetic nerve block in multiple adjacent thoracic dermatomes.…”
Section: Introductionmentioning
confidence: 99%
“…Elderly patients are a special population who have obvious differences from young people in terms of physiology, psychology, tumor condition, and their surgical tolerance and risk: they have multiple chronic diseases such as hypertension, coronary heart disease, heart failure, chronic obstructive pulmonary disease, etc; 8 , 9 , 10 they are more prone to cognitive impairment, depression, anxiety and other psychological problems; their tumor biology behavior is more malignant; all these lead to the need for more safe, effective, accurate, and less traumatic intervention methods for anesthesia and perioperative management process of elderly patients. 2 , 4 , 6 , 11…”
Section: Introductionmentioning
confidence: 99%
“…Each comorbidity is given a score of 1 (such as previous myocardial infarction), 2 (such as hemiplegia), 3 (such as moderate or severe liver disease), or 6 (such as malignant tumours) [ 14 ]. In COVID-19 patients, a CCI equal to or greater than 3 is associated with poor outcome [ 15 , 16 ]. The use of the CCI is widespread, especially in longitudinal studies, but has not been renewed since its creation in 1987 [ 17 , 18 ].…”
Section: Introductionmentioning
confidence: 99%